Explore the words cloud of the VARIXIO project. It provides you a very rough idea of what is the project "VARIXIO" about.
The following table provides information about the project.
VASCULAR BARCELONA DEVICES SL
|Coordinator Country||Spain [ES]|
|Total cost||71˙429 €|
|EC max contribution||50˙000 € (70%)|
1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
|Duration (year-month-day)||from 2019-12-01 to 2020-03-31|
Take a look of project's partnership.
|1||VASCULAR BARCELONA DEVICES SL||ES (Barcelona)||coordinator||50˙000.00|
Approximately 25% of adults have varicose veins, with prevalence increasing to over 80% if spider veins are also considered. The rising geriatric population is further accelerating these figures, as one in two people over the age of 50 are affected by varicose veins. In recent years, due to the possibility of infection and other adverse effects during invasive surgeries, traditional surgical treatment (surgical ligation and stripping) has given way to minimally invasive procedures, which also reduce hospital stays and costs. Consequently, a growing number of doctors are adopting foam sclerotherapy, endovenous laser treatment, and radiofrequency ablation over conventional surgical practices. Within these new treatment approaches, foam sclerotherapy is the preferred approach given its favourable efficacy and safety profile coupled with simplicity and relatively low cost. Foam sclerotherapy involves transforming a chemical sclerosing agent into foam and injecting it into the affected vein. The sclerosant foam irritates the lining of the blood vessel, causing it to collapse and stick together. Current manual foam preparation method broadly utilized by doctors (Tessari’s method) presents substantial limitations in terms of quality, consistency, versatility, and safety. VARIXIO Sclerotherapy Microfoam System being developed by VB Devices addresses these limitations by automating, standardizing, and greatly simplifying foam preparation. VARIXIO adds versatility and safety to this obsolote treatment method. Having secured patent protection for the device and validated the concept at the prototype level, the company is seeking funding to pursue industrial, regulatory, and commercial feasibility of the VARIXIO device.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "VARIXIO" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "VARIXIO" are provided by the European Opendata Portal: CORDIS opendata.
Utilizing an innovative chemical platform to defeat antimicrobial resistanceRead More
Dyme gives its users complete control over their financial situation. The Dyme application provides insight into users’ spending and subscriptions, and lets users cancel, negotiate, or switch any contRead More
IOT and cloud computing for online medical analysis service platformRead More